Title : Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo.

Pub. Date : 2021 Oct 6

PMID : 34703544






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo. Platinum albumin Homo sapiens
2 KP2156 forms very stable albumin adducts in the bloodstream resulting in a superior pharmacological profile, such as distinctly prolonged terminal excretion half-life and enhanced effective platinum dose (measured by ICP-MS). Platinum albumin Homo sapiens
3 Summarizing, albumin-binding of platinum(iv) complexes potently enhances the efficacy of oxaliplatin therapy and should be further developed towards clinical phase I trials. Platinum albumin Homo sapiens